The KDEL receptor is a Golgi/intermediate compartment-located integral membrane protein that carries out the retrieval of escaped ER proteins bearing a C-terminal KDEL sequence. This occurs throughout retrograde traffic mediated by COPI-coated transport carriers. The role of the C-terminal cytoplasmic domain of the KDEL receptor in this process has been investigated. Deletion of this domain did not affect receptor subcellular localization although cells expressing this truncated form of the receptor failed to retain KDEL ligands intracellularly. Permeabilized cells incubated with ATP and GTP exhibited tubular processes-mediated redistribution from the Golgi area to the ER of the wild-type receptor, whereas the truncated form lacking the C-terminal domain remained concentrated in the Golgi. As revealed with a peptidebinding assay, this domain did not interact with both coatomer and ARF-GAP unless serine 209 was mutated to aspartic acid. In contrast, alanine replacement of serine 209 inhibited coatomer/ARF-GAP recruitment, receptor redistribution into the ER, and intracellular retention of KDEL ligands. Serine 209 was phosphorylated by both cytosolic and recombinant protein kinase A (PKA) catalytic subunit. Inhibition of endogenous PKA activity with H89 blocked Golgi-ER transport of the native receptor but did not affect redistribution to the ER of a mutated form bearing aspartic acid at position 209. We conclude that PKA phosphorylation of serine 209 is required for the retrograde transport of the KDEL receptor from the Golgi complex to the ER from which the retrieval of proteins bearing the KDEL signal depends.
INTRODUCTION
In recent years, different retrograde transport routes have been described to be operative in the early secretory pathway. Together, these fulfills several important functions such as the retrieval of escaped endoplasmic reticulum (ER) proteins (Pelham, 1988; Dean and Pelham, 1990) , retention of misfolded proteins (Hammond and Helenius, 1994; Vashist et al., 2001) , recycling of Golgi glycosyltransferases (Storrie et al., 1998) , the internalization of bacterial and plant toxins (Lord and Roberts, 1998) , and the disassembly of the Golgi complex during mitosis (Zaal et al., 1999) . Among these, the recycling of ER residents has been particularly well studied. During normal anterograde flow a certain number of endogenous ER proteins continuously leave the organelle and reach downstream compartments in the secretory pathway where they are recognized and returned back to their original location (Pelham, 1991) . Soluble ER proteins such as chaperones and components of the control quality machinery contain a C-terminal KDEL (HDEL in yeast) sequence that is responsible for their recognition and retrieval from post-ER compartments (Munro and Pelham, 1987; Pelham et al., 1988) . The evolutionary extent of this pathway is illustrated by the fact that some bacterial toxins such as cholera toxin and Pseudomonas exotoxin A also contain a C-terminal KDEL sequence that allows them to reach the ER by retrograde transport after their uptake by endocytosis (Majoul et al., 1996; Jackson et al., 1999) . Throughout their association with molecular chaperones containing the KDEL signal misfolded proteins are also efficiently recovered from post-ER compartments and retained in the ER (Yamamoto et al., 2001) . Many ER transmembrane proteins, on the other hand, contain a dilysine (KKXX) motif at their C-terminus cytoplasmic tail. This is also a retrieval signal that allows recognition and subsequent retrograde transport (Nilsson et al., 1989; Jackson et al., 1990 Jackson et al., , 1993 .
In addition to KDEL and KKXX sorting signals displayed by ER residents, retrieval of these proteins depends on receptors that recognize the appropriate signals. ERD2, the KDEL receptor, is an integral membrane protein located at the Golgi complex and the ER-Golgi intermediate compartment (Lewis and Pelham, 1990; Semenza et al., 1990; Griffiths et al., 1994) . At these locations the receptor specifically binds KDEL-bearing proteins with high affinity and mediates their uptake into transport intermediates (Lewis and Pelham, 1992) . These ferry the ligand-receptor complexes to the ER where dissociation occurs. Ligands are thus released within the ER and the receptor is recycled back to the Golgi for further rounds of transport. pH differences between the ER and the Golgi have been proposed to account for the different affinities exhibited by the receptor toward ligands at both locations .
COPI-coated transport intermediates, either in the form of round vesicles or as tubular processes, mediate retrograde traffic followed by both the KDEL receptor-ligand complexes and membrane proteins containing a dilysine retrieval motif Orci et al., 1997; Presley et al., 1998) . Formation of these carriers depends on a highly conserved transport ma-chinery (Wieland and Harter, 1999 ). An essential component of this machinery is coatomer, a heptameric protein complex that is recruited from cytosol to the membrane before budding. Coatomer recruitment, in turn, requires previous association of ARF1, a ras-like GTPase that in its GTP-bound form initiates COPI coat assembly (Barlowe, 2000; Donaldson and Lippincott-Schwartz, 2000) . Thus, ARF1-GTP binds to the Golgi/intermediate compartment membranes and recruits coatomer. ARF1 activation consists in the exchange of GDP for GTP catalyzed by an ARF1-specific guanine nucleotide exchange factor (GEF; Jackson and Casanova, 2000) . By contrast, hydrolysis of GTP by ARF1 gives rise to its deactivation. This reaction is regulated by a Golgi-associated GTPase-activating protein (ARF-GAP; Cukierman et al., 1995) , and recent studies indicate that this activity is also required for cargo sorting and budding (Lanoix et al., 2001; Yang et al., 2002) . Additional constituents of the COPIcoated transport intermediates are the p24 proteins, which are type I transmembrane proteins that have been proposed to function in both cargo selection and coat recruitment (Kaiser, 2000) .
Although the KDEL recycling pathway is well established, several important questions remain unanswered. In particular, how the occupied KDEL receptor is sorted into COPIcoated transport intermediates is largely unknown. Recent studies indicate that upon ligand binding the receptor oligomerizes and interacts with components of the transport machinery such as ARF-GAP and ARF1 (Aoe et al., 1997 (Aoe et al., , 1998 Majoul et al., 2001) . This most likely contributes to the formation at the donor membrane of prebudding complexes that should facilitate evagination. However, it does not explain the mechanism that allows the occupied receptor to be sorted, whereas the unoccupied receptor would be excluded. In principle, sorting would take place throughout the interaction of COPI coat proteins with the cytoplasmic domains of the KDEL receptor (Bremser et al., 1999; Wieland and Harter, 1999) . The latter should bear some kind of ER retrieval motif for that. However, no such a signal has been characterized for the KDEL receptor so far, and therefore the mechanism of sorting of this protein remains unresolved. In this study, we have analyzed the functional role played by the C-terminal cytoplasmic domain of the KDEL receptor. The results indicate that this protein region is phosphorylated by cAMP-dependent protein kinase A (PKA). This phosphorylation event allows the interaction of the KDEL receptor with ARF-GAP and coatomer proteins, which in turn determines both the Golgi-ER retrograde transport followed by the receptor and the retrieval of ligands containing the KDEL signal.
MATERIALS AND METHODS

Reagents
Expression in bacteria and purification of His-tagged recombinant proteins (murine RII␣ and YFP-Sar1 dn ) was performed as described (Martín et al., 1999) . Tissue culture media and antibiotics were from Life Technologies (Paisley, Scotland, United Kingdom) and restriction endonucleases from Roche Diagnostics (Mannheim, Germany). C␣ and H89 were purchased from Calbiochem (La Jolla, CA). Protein G-Sepharose, ATP, GTP, DTT, and protease inhibitors were from Sigma-Aldrich (St. Louis, MO). Streptolysin O (SLO) was purchased from Dr. H. G. Meyer (University of Mainz, Germany). The following antibodies were provided by other investigators: F6.26.1 mouse mAb against hen lysozyme (M.M. Riottot, Institut Pasteur, Paris, France; Goldbaum et al., 1999) , 12G5 mouse mAb against CXCR4 (Dr. A. Caruz, University of Jaen, Spain; Amara et al., 1997) , and rabbit polyclonal against GMAP-210 (Dr. R. Rios, University of Seville, Spain; Infante et al., 1999) . Mouse monoclonal against the C-terminal domain of the native bovine KDEL receptor was from Stressgen Biotechnologies (Victoria, BC, Canada), 9E10 mouse monoclonal against c-myc from Roche Diagnostics, goat polyclonal to ARF-GAP1 from Abcam (Cambridgeshire, United Kingdom), FITC-and HRP-conjugated secondary antibodies from Biosource (Camarillo, CA), and Texas Red-labeled secondary antibodies from Molecular Probes (Eugene, OR). Rabbit polyclonals against coatomer proteins were purchased from Dr. F. Wieland (BZH, Heidelberg, Germany) .
DNA Construction and Production of Recombinant Baculoviruses
Plasmid HE24M coding a version of the human KDEL receptor containing a c-myc epitope inserted between the last transmembrane domain and the C-terminal cytoplasmic domain was generated by site-directed mutagenesis according to the overlapping extension technique (Ho et al., 1989 ). An EcoRVBamHI fragment of the coding sequence present in plasmid HE24 (provided by Dr. H.R.B. Pelham, MRC, UK; Lewis and Pelham, 1990 ) was subcloned into pBluescript II SK (Stratagene, La Jolla, CA) and used as template. Single amino acid changes and deletion of the C-terminal domain were also carried out by this method. For expression, modified sequences were returned to the original vector by replacement. Simultaneous expression of both lysozyme-KDEL and c-myc-tagged versions of the KDEL receptor was achieved by inserting a XhoI-NcoI fragment of HE24M into HYKE4 plasmid (provided by Dr. L.M. Roberts, Warwick University, UK; Jackson et al., 1999) . To generate KDEL receptor fluorescent constructs, variants of the green fluorescent protein, namely enhanced cyan fluorescent protein (CFP) and enhanced yellow protein (YFP), were fused to the C-terminus of the receptor. Sequences coding different KDEL receptor variants were subcloned into pECFPN1 and pEY-FPN1 vectors (Clontech, BD Biosciences Clontech, Palo Alto, CA). The overlapping extension procedure was also used to replace the C-terminal domain of CXCR4 with that of the native KDEL receptor. Templates in this case were an expression plasmid coding wild-type CXCR4 (provided by Dr. A. Caruz; Amara et al., 1997) and the above mentioned pBluescript vector containing a C terminal fragment of the KDEL receptor. Oligonucleotides coding amino acids 307-311 of CXCR4 and amino acids 200 -205 of the KDEL receptor were used as primers. The resulting chimera was subcloned into the original CXCR4 expression vector. All constructs were verified by DNA sequencing. To generate recombinant baculoviruses, EcoRI and XhoI restriction sites were inserted at the N and C ends, respectively, of the coding sequence of HE24M. This fragment was subcloned into pFastBacI (Life Technologies). Baculoviruses were obtained in bacmid-transfected Sf9 insect cells according to the instructions provided by the manufacturer. The vector pEYFPC2-Sar1p dn coding a YFP-tagged version of the dominant-negative mutant form of Sar1 (Sar1[H79G], Sar1 dn ) was provided by Dr. R. Pepperkok (EMBL, Heidelberg, Germany). For expression in bacteria a NcoI-BamHI fragment was subloned into pRSETB (Invitrogen, Carlsbad, CA).
Membrane and Cytosol Preparations
Cytosol was prepared from either bovine brain or rat liver as described (Hidalgo et al., 1995; Martín et al., 2000) . Total microsomes were prepared from Sf9 insect cells infected with recombinant baculoviruses. Cells (5-7 ϫ 10 8 ) were harvested 50 -60 h postinfection by centrifugation at 400 ϫ g for 10 min. They were rinsed with cold PBS and resuspended in 12-15 ml of 0.25 M sucrose in 25 mM HEPES, pH 7.2, 5 mM MgCl 2 containing protease inhibitors (1 mM PMSF, 5 mM benzamidine, 100 g/ml soybean trypsin inhibitor, 20 g/ml aprotinin, and 10 g/ml each pepstatin A, leupeptin, antipain). Homogenization was performed in a ball-bearing homogenizer. The homogenate was centrifuged at 12,000 ϫ g for 10 min at 4°C to remove nuclei, mitochondria, and unbroken cells. The supernatant was centrifuged at 100,000 ϫ g for 1 h at 4°C. Membranes were incubated on ice with 3 M KCl for 30 min. They were recovered by centrifugation as above on a 2 M sucrose cushion. Microsomes were resuspended in 25 mM HEPES-KOH, pH 7.2, 25 mM KCl, and 2.5 mM MgCl 2 at 5-9 mg/ml protein concentration, snap-frozen in liquid nitrogen, and stored at Ϫ80°C.
Mammalian Cell Culture, Transient Transfection, Microinjection, and Immunofluorescence
Vero and COS-7 cells were grown in MEM and DMEM, respectively, and supplemented with 10% (vol/vol) FCS, 2 mM l-glutamine, 50 U/ml penicillin, and 50 g/ml streptomycin. Cells were transfected by electroporation. Briefly, 1-2 ϫ 10 6 cells were resuspended in 0.2 ml of hypoosmolar electroporation buffer (Eppendorf, Hamburg, Germany) containing 12 g of pure plasmid DNA and 14 g sperm DNA. The cell suspension was transferred into a 4-mm gap sterile cuvette. Electroporation was carried out in Multiporator (Eppendorf) at 600 v, : 100 s. Cells were diluted in complete culture medium containing 15 mM HEPES and recovered by centrifugation at 400 ϫ g for 10 min. They were used 24 -48 h posttransfection. Cells grown on glass coverslips for 1 d were microinjected into the cytoplasm with 2 mg/ml YFP-tagged Sar1 dn using an Automated Microinjection System (Eppendorf). For indirect immunofluorescence, cells were fixed for 5 min in cold methanol or, alternatively, for 20 min in 3% (wt/vol) paraformaldehyde in PBS. They were rinsed several times with plain PBS and PBS/0.5%(wt/vol) BSA/ 0.05%(wt/vol) saponin. Incubation with antibodies diluted in PBS/BSA/ saponin was performed at 37°C for 30 min. Cells were rinsed with PBS and mounted with Fluoromont G (Southern Biotechnology, Birmingham, AL).
Golgi-ER Redistribution Assay
Cells cultured on glass coverslips were rinsed with ice-cold buffer (20 mM HEPES, pH 7.2, 2 mM magnesium acetate, 90 mM potassium acetate, 1 mM DTT). They were incubated on ice for 20 min with 1 g/ml SLO. Coverslips were rinsed thoroughly with cold buffer and then incubated at 37°C with 0.3 ml buffer containing 1 mM of both ATP and GTP in a 17-mm well of a 24-well dish.
Lysozyme Secretion
After transfection, 0.5 ϫ 10 6 cells were plated on each 35-mm well of a six-well dish. One day after, the cells were depleted by incubation with methionineand cysteine-free medium for 30 min and then radiolabeled at 37°C for 10 min with 1 ml of the same medium containing 25 mCi Tran 35 S-label (1000 Ci/ mmol). They were rinsed with ice-cold PBS and chased in 0.5 ml of complete medium containing 1.5 mg/ml both unlabeled methionine and cysteine. At each time point, the medium was collected and the cells were washed with cold PBS and lysed with 0.4 ml lysis buffer (25 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% [vol/vol] Triton X-100) containing protease inhibitors. Samples were cleared by centrifugation at 12,000 ϫ g for 20 min at 4°C, and supernatants were transferred to new tubes. Media samples were mixed with 0.5 ml of 2ϫ lysis buffer. Incubation with antibody against hen lysozyme was carried out overnight at 4°C followed by 1-h treatment with protein GSepharose. Immunoprecipitates were rinsed with the above buffer supplemented with 1% (wt/vol) sodium deoxycholate and 0.1% (wt/vol) SDS (RIPA buffer) and 10 mM Tris-HCl, pH 7.8, before electrophoresis.
Peptide-binding Assay
Synthetic peptides were coupled to thiopropyl Sepharose 4B (Amersham, Piscataway, NJ) according to the manufacturer's instructions. Coupled peptides (2-3 nmol) were incubated at room temperature for 5 min with 200 g bovine brain cytosol in 0.5 ml coupling buffer (50 mM Tris-HCl, pH 7.3, 0.1-1 M NaCl). Beads were rinsed several times with coupling buffer before processing for electrophoresis.
Phosphorylation Assay
High salt-washed microsomal membranes (35 g) were incubated at 30°C for 10 min with 0.1 Ci [ ␥-32 P]ATP (3000 Ci/mmol) and 1 U PKA catalytic subunit (C␣) in phosphorylation buffer (20 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 1 mM DTT). Alternatively, 100 g crude rat liver cytosol and phosphatase inhibitors (10 mM sodium pyrophosphate, 20 mM NaF) were added to the incubation medium instead of C␣. Final volume was, in all cases, 50 l. The reaction was stopped by transferring the tubes to ice and adding 1 ml of ice-cold phosphorylation-arresting buffer (20 mM Tris-HCl, pH 7.5, 100 mM ATP, 100 mM EDTA). Membranes were pelleted at 12,000 ϫ g for 20 min at 4°C, rinsed with phosphorylation-arresting buffer, and lysed in 0.5 ml RIPA buffer. The KDEL receptor constructs were immunoprecipitated with antimyc antibody and protein G-Sepharose.
Electrophoresis and Immunoblot Analysis
Beads with bound proteins were resuspended in electrophoresis sample buffer, reduced with 10 mM DTT, and boiled for 5 min. SDS-PAGE, 15%, gels were used to resolve both lysozyme and KDEL receptor molecules, whereas coatomer proteins were separated on 10% SDS-PAGE gels. Proteins were transferred onto either nitrocellulose or polyvinylidene difluoride (Immobilon-P, Millipore, Bedford, MA) membranes. Blots were blocked overnight at 4°C with 5% (wt/vol) nonfat milk in TBS containing 1% (vol/vol) Tween 20. They were incubated with primary antibody for 1 h at room temperature followed by treatment with the corresponding HRP-conjugated secondary antibody. Signals were detected by ECL (SuperSignal; Pierce Chemical Co., Rockford, IL) and quantitated by scanning densitometry. Alternatively, 35 Sand 32 P-labeled proteins were visualized in PhosphorImager (FUJIXBas 1000; Fuji, Tokyo, Japan) using PC-BAS 2.08 software.
RESULTS
Role of the C-terminal Domain in Subcellular Localization of the KDEL Receptor and Retrieval of KDEL Ligands
The KDEL receptor is believed to adopt a seven-transmembrane-domain topology with a short, 12-13-amino acid tail at the C terminus projecting out of the membrane toward the cytosol (Townsley et al., 1993; Scheel and Pelham, 1998) . To analyze the functional role of this domain, we inserted a c-myc epitope between the last transmembrane domain and the putative cytoplasmic tail, which is between amino acids 199 -200 of the native protein. When expressed in COS cells this tagged version of the receptor localized at the Golgi complex as evidenced by double immunofluorescence staining with an antibody specific for GMAP-210, a protein associated to the cis-Golgi network (Infante et al., 1999;  Figure  1A ). This indicated that the presence of the intercalated myc sequence did not affect the normal, steady state localization of the receptor. Deletion of the last 12 amino acids of our construct leaves the myc epitope only covered by a threonine residue at the C terminus. This truncated form of the receptor was still localized at the Golgi complex ( Figure 1A) , suggesting the absence of targeting signals within the Cterminal domain. To test this we investigated the conse- quences of replacing the C-terminal domain of a plasma membrane protein with that of the native KDEL receptor. CXCR4, a chemokine receptor, was chosen because of its structural similarity with the KDEL receptor (Amara et al., 1997) . Both the chimera and the wild-type protein were able to travel throughout the exocytic pathway to the plasma membrane when expressed in COS cells ( Figure 1B ). Therefore, according to these results the C-terminal domain does not confer Golgi retention to a reporter protein.
We examined the role of this domain in the retrieval from the Golgi to the ER of proteins bearing the KDEL signal at their C terminus. Cells expressing lysozyme-KDEL were pulse-labeled and chased to monitor secretion of this protein to the medium. As shown in Figure 2A , a significant amount (21%) of the initially labeled lysozyme-KDEL was secreted to the medium during a 3-h chase period, indicating saturation of the endogenous retrieval system. By contrast, secretion of lysozyme-KDEL did not occur in cells simultaneously expressing the wild-type, myc-tagged version of the KDEL receptor ( Figure 2B ). In these cells, lysozyme-KDEL was localized in the ER by immunofluorescence, whereas the receptor, detected with anti-myc antibody, was mostly concentrated in the perinuclear Golgi region (our unpublished results). This indicated that the efficiency of retrieval was restored after expression of the ectopic receptor that was, therefore, fully functional in terms of ligand recognition and recovery at the Golgi complex. By contrast, during a 4-h chase period 44 -47% of the initially labeled lysozyme molecules were secreted to the medium by cells expressing a truncated form of the KDEL receptor lacking the C-terminal domain ( Figure 2B ). This suggests a severe defect in the cellular mechanisms that are responsible for the normal retention of escaped ER proteins.
The C-terminal Domain Is Required for the Transport of KDEL Receptor from the Golgi Complex to the ER To gain insight on the role played by the C-terminal domain in retrograde transport we designed a morphological assay aimed to monitor the redistribution into the ER of the KDEL receptor. SLO-permeabilized cells were incubated at 37°C in the presence of both ATP and GTP. Under these conditions the endogenous receptor left the Golgi complex into elongated tubular processes that with time fragmented and fused with the ER (Figure 3 ). In addition to ATP and GTP, this process seemed to require residual cytosolic factors remaining inside the cells. Thus, permeabilized cells that were rinsed with high-salt buffer before incubation could not drive tubule formation. Addition of exogenous cytosol did not restore the cytosolic factors lost during the high salt wash (our unpublished results).
Cells expressing fluorescently tagged versions of the KDEL receptor were permeabilized and used in the redistribution assay. The wild-type receptor readily redistributed into the ER after incubation with both ATP and GTP whereas it remained localized in the Golgi in their absence (Figure 4) . In contrast, a truncated form of the receptor lacking the C-terminal domain did not redistribute either in the presence or in the absence of ATP and GTP. This suggested the existence of differences in the ability of both molecular forms to participate in the Golgi-ER retrograde pathway. To reveal such differences, we used immunofluorescence staining with an antibody against the C-terminal domain. Cells expressing the truncated form of the receptor and incubated for 30 -35 min with ATP and GTP showed the endogenous receptor, recognized by the antibody, redistributed into the ER, whereas the ectopic fluorescent form lacking the C-terminal domain remained retained in the Golgi (Figure 4 ). This clearly indicated that transport from the Golgi complex to the ER of the KDEL receptor depends on its C terminus.
Role of the C-terminal Domain in the Interaction of the KDEL Receptor with Coatomer and ARF-GAP
In the Golgi-ER retrograde pathway, sorting of membrane proteins occurs throughout the interaction of coat proteins with their cytoplasmic domains. The latter typically bear some kind of ER retrieval motif such as a dilysine (KKXX) motif at their C-terminus. Although apparently the KDEL receptor lacks such a signal, it is well established that it is transported from the Golgi complex to the ER in COPIcoated transport intermediates (Orci et al., 1997; Girod et al., 1999) . Therefore, in order to be sorted into this kind of carriers the KDEL receptor must interact with components of the COP I coat. To examine this, we carried out pull-down experiments of cytosolic coatomer proteins with synthetic peptides corresponding to the C-terminal domain of the KDEL receptor coupled to beads ( Figure 5, A and B ). On incubation with cytosol the beads were rinsed and processed by SDS-PAGE before protein detection by immunoblotting. Recruitment was dependent on peptide because control beads with no peptide coupled did not bind any coatomer protein. At 0.1 M NaCl a 21-amino acid peptide covering the complete C-terminal domain of the KDEL receptor did not recruit coatomer. However, a small amount of some coatomer proteins such as ␤Ј-COP and ␥-COP could be bound at higher, 0.5-1 M, NaCl concentration ( Figure 5A ). Interestingly, this peptide sequence contains at positions Ϫ6 and Ϫ7 from the C terminus two consecutive lysine residues. Although located far away from the C terminus, these residues could be part of a hidden ER retrieval motif that under certain circumstances would be exposed for interaction with coatomer. To investigate this possibility a similar peptide lacking the last three amino acids was also assayed. Despite the presence of a potential retrieval dilysine motif at the C terminus coatomer proteins did not interact either with this peptide sequence ( Figure 5A ). Therefore, other factors different from the classic dilysine retrieval motif would be responsible for the interaction of the C-terminal domain of the KDEL receptor with coatomer proteins. Thus, a serine residue located at position 209 in the native protein was shown to be critical for interaction. Even at high salt concentration no coatomer protein bound to a peptide sequence in which this particular amino acid was omitted. We reasoned that serine 209 could be a potential phosphorylation target. Accordingly, serine was replaced by either alanine, which cannot be phosphorylated, or alternatively, by aspartic acid, which mimics a phosphorylated residue. The latter peptide sequence was able to recruit coatomer under all conditions assayed. By contrast, alanine replacement abolished coatomer binding ( Figure 5A ). These results suggested that phosphorylation of serine 209 would determine the interaction of the C-terminal domain of the KDEL receptor with cytosolic coatomer proteins.
Although phosphorylation of serine 209 could be a relevant event, additional determinants might be also involved in coatomer binding. As mentioned above, a putative dilysine motif is present within the C-terminal domain of the KDEL receptor. In principle, this motif should not be functional in retrieval because it is located far away from the C terminus. Figure 5B shows that peptides in which this motif was altered by alanine replacement did not bind coatomer proteins. Apparently, this situation could not be overcome by phosphorylation of serine 209. Thus, a peptide lacking an intact dilysine motif and simultaneously containing an aspartic acid residue at a position equivalent to 209 in the native protein could not bind coatomer ( Figure 5B ). Therefore, in addition to phosphorylation of serine 209, a functional dilysine retrieval motif must be present within the C-terminal domain of the KDEL receptor for coatomer interaction to occur.
The KDEL receptor, on the other hand, has been shown to interact with ARF-GAP in a ligand-stimulated process (Aoe et al., 1997 (Aoe et al., , 1998 ). This interaction is thought to promote ARF-GAP recruitment from cytosol to the membrane where ARF-GAP has been described to participate in cargo sorting and formation of COPI-coated transport carriers (Yang et al., 2002) . We asked whether the amino acid determinants involved in coatomer recruitment also affected the interaction of the KDEL receptor with cytosolic ARF-GAP ( Figure 5C ). In our assay, ARF-GAP did not bind to a peptide corresponding to the complete Cterminal domain of the KDEL receptor unless serine 209 was replaced by aspartic acid. Again, the internal dilysine motif had a dominant effect because no binding occurred when it was altered by alanine replacement either in the presence or in the absence of aspartic acid at a position equivalent to 209 in the native protein ( Figure 5C ). Taken together, these results suggest that phosphorylation of serine 209 promotes the interaction of the KDEL receptor with both coatomer proteins and ARF-GAP. 
Role of Serine 209 in Golgi-ER Transport and Retrieval of KDEL Ligands
The above data suggested that within the C-terminal domain serine 209 could play a critical role in the interaction of the KDEL receptor with COPI coat proteins and hence in the Golgi-ER retrograde transport followed by the former. To investigate this further, we analyzed the redistribution of a mutated form of the receptor in which this particular amino acid was replaced by alanine. Cells expressing fluorescently tagged forms of both the wild-type and the S209A mutated receptor were permeabilized and used in the redistribution assay. During a 25-30-min incubation period a significant amount of the wild-type receptor redistributed to the ER in an ATP-and GTP-dependent manner. In contrast, the S209A mutated receptor lagged behind in the Golgi ( Figure 6A ) and only after prolonged (40 -45 min) incubation periods started to appear in the ER network. This is consistent with the fact that most of the Golgi residents redistributed to the ER after long incubations (our unpublished results). These results revealed striking differences between both molecular forms in their ability to be transported from the Golgi complex to the ER within the same living cell. According to these data the S209A receptor does not travel from the Golgi to the ER at normal speed and most likely this could affect the retrieval of ligands containing the KDEL sequence. We therefore examined the effect of this amino acid replacement on the intracellular retention of lysozyme-KDEL ( Figure 6B ). Cells expressing simultaneously lysozyme-KDEL and either the wild-type or the S209A mutated receptor were pulselabeled and chased for 3 h. During this time period 18.2% of the initially labeled lysozyme-KDEL was secreted to the culture medium by cells expressing the S209A mutant form. Because lysozyme-KDEL was not secreted to the medium by cells expressing the wild-type receptor ( Figure 6B ), this result indicated that expression of the mutated receptor decreased the efficiency of the retrieval system.
PKA Phosphorylation of the KDEL Receptor
The above data indicated that serine 209 is a key residue for the normal functioning of the KDEL receptor. The sequence context in which Serine 209 is located (KKLSL) is a potential consensus site for PKA phosphorylation (K/R-K/R-X-S-X). We therefore examined the possibility that this kinase might be involved in phosphorylation of the C-terminal domain of the KDEL receptor (Figure 7) . High-salt-washed microsomal membranes from insect cells expressing different versions of the myc-tagged KDEL receptor were incubated with both [␥-32 P]ATP and pure PKA catalytic subunits, C␣. Membranes were then rinsed with buffer and lysed. The KDEL receptor constructs were immunoprecipitated with anti-myc antibody, subjected to SDS-PAGE, and transferred to Western blots. Protein bands labeled with 32 P were identified by immunoblotting with anti-myc antibody. The wild-type KDEL receptor was efficiently phosphorylated in a C␣-dependent reaction. By contrast, the S209A mutant form was not phosphorylated either in the absence or in the presence of C␣ in the incubation medium ( Figure 7A ). Phosphorylation of the wild-type KDEL receptor could also be achieved by incubation with crude cytosol ( Figure 7B ). An endogenous kinase activity catalyzed receptor phosphorylation in this case. We identified such kinase activity as PKA by using cytosol preincubated with pure RII␣ regulatory subunits. These are expected to complex and inactivate endogenous C␣ subunits present in the cytosol preparation. As shown in Figure 7B , addition of 50 -100 nM RII␣ abolished KDEL receptor phosphorylation induced by cytosol.
These data implied that PKA could potentially phosphorylate the C-terminal domain of the KDEL receptor at serine 209. The question that arose was the functional relevance of such modification. To address this, we performed an experiment aimed to evaluate the role of PKA phosphorylation in the dynamic cycling of the endogenous KDEL receptor. A GTP-restricted form of Sar1 (Sar1[H79G], Sar1 dn ) was used as a specific reagent to arrest the anterograde ER-Golgi transport while leaving the retrograde Golgi-ER pathway unaffected. Nontransfected cells were microinjected with recombinant Sar1 dn -tagged with YFP. In the presence of this protein the KDEL receptor redistributed to the ER where it became trapped. This effect was observed in most (66%, n ϭ 115) of the microinjected cells and seems to be the result of a situation of continuous retrograde transport in the absence of anterograde flow. By contrast, noninjected cells showed the typical Golgi/intermediate compartment localization pattern (Figure 8 ). We next used H89 as a selective inhibitor to reveal the involvement of PKA in the transport of the native receptor from the Golgi to the ER. Used at 5-10 M, this reagent specifically inhibits PKA activity, whereas much higher concentrations (mM range) are required to inhibit other serine/threonine kinases. In cells incubated with 5 M H89 the KDEL receptor was seen concentrated in the Golgi area either in the presence or in the absence of Sar1 dn ( Figure  8 ). Because redistribution did not occur in Ͼ70% of the cells microinjected with Sar1 dn , this result indicated that the Figure 5 . Interaction of native coatomer proteins and ARF-GAP with peptides. Synthetic peptides were covalently coupled to thiopropyl Sepharose beads. They were incubated with crude bovine brain cytosol for 5 min at room temperature, rinsed with buffer, and processed by SDS-PAGE and immunoblotting. The same Western blot membrane was reused to detect several coatomer proteins. Incubation with cytosol and rinses with buffer were carried out at the indicated NaCl concentrations (A) or, alternatively, at 0.1 M NaCl (B and C). Peptide . . . GKKLSLPA corresponds to the entire C-terminal domain of the native KDEL receptor. Changes on this sequence are indicated as underlined residues and the caret indicates deletion). As a negative control, beads with no peptide coupled were similarly processed (control). Also, 20 g of crude cytosol was processed and loaded on gels as a positive control (cytosol).
transport of the native receptor from the Golgi to the ER is indeed PKA modulated. We took advantage of the inhibitory effect of H89 on ER-Golgi anterograde transport (Muñ iz et al., 1996; Aridor and Balch, 2000; Lee and Linstedt, 2000) to demonstrate the redistribution from the Golgi to the ER of the S209D mutant receptor. We reasoned that if this form would mimic a phosphorylated receptor, it would travel from the Golgi to the ER in a H89 insensitive way. Then it would be retained in the ER because of blocking of the anterograde transport. Cells expressing fluorescently tagged versions of both the wild-type KDEL receptor and the S209D mutated form were therefore subjected to H89 treatment. Both molecular forms colocalized at the Golgi complex in control, untreated cells ( Figure 9 ). As expected from the above data, H89 inhibited ER redistribution of the wild-type KDEL receptor that remained localized at the Golgi after 1-h incubation with a high dose, 20 -30 M, of this inhibitor. By contrast, under these conditions the mutant S209D receptor expressed by the same cell redistributed efficiently from the Golgi to the ER (Figure 9 ). These results emphasized the relevance of PKA phosphorylation of serine 209 to promote the retrograde traffic of the native KDEL receptor from the Golgi complex to the ER.
DISCUSSION
Retrieval of endogenous ER proteins tagged with the KDEL-(HDEL) sequence at their C-terminus is an essential, conserved process in eukaryotic cells that contributes to the quality control in the secretory pathway. The wild-type KDEL receptor does not contain a classic dilysine ER retrieval motif. Despite of this, it is firmly established that, once loaded with cargo, the KDEL receptor travels from the Golgi complex to the ER in COPI-coated transport carriers (Orci et al., 1997; Girod et al., 1999) . Therefore the mechanism that allows the receptor-ligand complexes to be sorted into these containers is a major unresolved problem.
In this study we have analyzed the functional role of the C-terminal cytoplasmic domain of the KDEL receptor. According to our results, this part of the protein does not contain dominant targeting information that could direct the KDEL receptor or any other membrane protein to the Golgi complex. By contrast, the data indicate that it is necessary for receptor sorting into COPI-coated transport intermediates and, therefore, is required for the retrograde transport of the KDEL receptor from the Golgi region to the ER as well as for the retrieval of KDEL ligands. Thus, in a Golgi-ER redistribution assay that makes use of SLO-permeabilized cells a Cells expressing either the wild-type receptor (WT) or the S209A mutant form were pulselabeled for 10 min and chased for 3 h. Lysozyme-KDEL was immunoprecipitated from both medium (M) and cell pellet (C) and resolved by SDS-PAGE. truncated form of the receptor lacking the C-terminal domain remained retained in the Golgi complex, whereas the native receptor present in the same cell efficiently redistributed to the ER. Accordingly, a significant amount of lysozyme-KDEL was secreted to the extracellular medium by cells expressing this truncated form of the KDEL receptor. In contrast, those expressing the wild-type form retained lysozyme-KDEL intracellularly. Together, these results indicate that the short C-terminal domain plays an essential role for the functioning of the KDEL receptor. A relevant role of the C-terminal domain in retrograde transport is also supported by studies showing that the arrival of KDEL-bearing bacterial toxins to the ER is inhibited in cells microinjected with antibodies directed against this region of the receptor (Majoul et al., 1998; Jackson et al., 1999) . Alternatively, it is possible that tail-less forms of the KDEL receptor would become aggregated in the Golgi complex where they would be unable to participate in retrograde transport.
Within the C-terminal domain serine 209 is an important residue for the function of the KDEL receptor. Replacement by alanine (S209A) affected the ability of the receptor to be transported from the Golgi complex to the ER as judged by results obtained with the redistribution assay. At least in this case formation of molecular aggregates that could not be transported along the retrograde pathway seems unlikely. The S209A mutant form remained arrested in the Golgi complex, whereas the wild-type receptor expressed by the same cell redistributed to ER at normal speed. Additionally, intact cells expressing the S209A mutant form did not retain lysozyme-KDEL properly. In contrast to these findings, Townsley et al. (1993) reported that point mutations at the different predicted cytoplasmic domains of the KDEL receptor including the C-terminal tail did not affect its retrograde traffic from the Golgi to the ER. This was evaluated by receptor redistribution to the ER during coexpression with lysozyme-KDEL. In particular, alanine replacement of serine 209 did not prevent receptor relocation to the ER induced by overexpression of lysozyme-KDEL. Instead, using the same criteria an aspartic acid residue located in the seventh transmembrane domain was judged to be critical for retrograde transport (Townsley et al., 1993) . The molecular versions of the KDEL receptor here analyzed, including the S209A and S209D mutant forms and also a truncated form lacking the entire C-terminal domain, were all concentrated at the Golgi complex during transient expression. Still they exhibited different capabilities to be transported from the Golgi to the ER as shown by their relative contribution to the intracellular retention of lysozyme-KDEL. This indicates that receptor localization pattern is determined by several factors (i.e., ER-Golgi anterograde transport) and is not necessarily an indication of its functionality.
Phosphorylation of serine 209 seems be a key event in controlling the dynamic behavior of the KDEL receptor. The available evidences indicate that PKA is involved. Thus, the receptor can be phosphorylated in vitro by both pure, recombinant PKA catalytic subunit and by a cytosolic activity inhibited by PKA regulatory subunits. Involvement of PKA in Golgi-ER retrograde transport is supported by experiments with H89. Cells incubated with low concentrations of this inhibitor did not show redistribution of the native KDEL receptor from the Golgi region to the ER after a block in the ER-Golgi anterograde flow induced by Sar1 dn . This suggests that in order to be transported from the Golgi complex to the ER the KDEL receptor must be first phosphorylated by PKA. Conversely, in the absence of PKA phosphorylation the native receptor would not be recruited into the Golgi-ER retrograde pathway and proteins bearing the KDEL signal would be secreted to the extracellular medium. In addition, because of its inhibitory effect on ER to Golgi anterograde transport (Muñ iz et al., 1996; Aridor and Balch, 2000; Lee and Linstedt, 2000) H89 was used to evaluate the consequences of the S209D mutation. In this case, treatment with H89 does not interfere with the Golgi-ER retrograde traffic of the S209D mutant form but inhibits exit from the ER and this gives rise to retention at this location. Presence of an aspartic acid at position 209 would mimic a phosphorylated residue. This could have the effect of making the KDEL receptor to be permanently activated for retrograde transport. However, the Golgi localization pattern of this form in untreated cells suggests that it is also rapidly moving out of the ER to the Golgi.
Our observations indicate that the C-terminal domain is involved in the interaction of the KDEL receptor with components of the COPI coat such as coatomer proteins and also with the ARF1 regulator ARF-GAP. We have been able to study such interaction in assays using synthetic peptides that mimic the cytoplasmic tail of the KDEL receptor. From these experiments we conclude that binding of both coatomer proteins and ARF-GAP apparently depends on two factors. First, a hidden dilysine motif is required. This corroborates a recent study showing that mutation of these residues abolishes the interaction of the cytoplasmic domain with purified coatomer and recombinant ARF-GAP (Yang et al., 2002) . On the other hand, serine 209 was shown to be critical for both coatomer and ARF-GAP recruitment. Binding in both cases was maximal after replacement of this residue by aspartic acid, whereas it was abolished after alanine replacement. This result places PKA phosphoryla- Figure 9 . Effect of H89 treatment on the Golgi-ER redistribution of the S209D mutant form of the KDEL receptor. Vero cells were cotransfected with two plasmids, one coding a YFP-tagged version of the wild-type KDEL receptor and the other coding a CFP-tagged version of a mutant form in which S209 was changed to D (S209D). Twenty-four hours after transfection they were incubated or not (Ϫ) at 37°C for 1 h with 20 M H89 in FCS-free medium before fixation. Bars, 16 m tion in the center of the regulation of the interaction of the KDEL receptor with the retrograde transport machinery. A possibility would be that PKA phosphorylation of serine 209 could trigger a conformational change in the C-terminal domain of the KDEL receptor. This would result in the cryptic dilysine motif becoming exposed and available for interaction with ARF-GAP and coatomer. Although this mechanism might occur in mammalian cells, it certainly does not apply to other cell systems. Thus, neither the internal dilysine motif nor the critical serine residue are strictly conserved in evolution. For instance, the C-terminal domain of the yeast HDEL receptor have only one lysine residue, which is not sufficient to constitute a retrieval motif. Furthermore, no serine or other phospho-acceptor residue is present in such domain (Semenza et al., 1990) . Interestingly, the two determinants here discussed are present in the Cterminal domain of yeast Rer1, which also functions in retrograde transport as a receptor for the COPI-dependent retrieval of certain type II transmembrane proteins (Nishikawa and Nakano, 1993; Boehm et al., 1997) . Therefore, it is possible that PKA activity regulates the interaction with the COPI transport machinery of several membrane receptors in different organisms.
We postulate the existence of a signal-transduction pathway across the membrane of the Golgi complex. This could become activated once the KDEL receptor interacts with ligands. The predicted topology of the KDEL receptor, structurally similar to G-protein-coupled receptors, supports the existence of such a pathway (Townsley et al., 1993; Scheel and Pelham, 1998) . PKA, on the other hand, is associated to the cytoplasmic side of the Golgi membranes (Martín et al., 1999) , and it could also be activated upon ligand binding. Activated PKA phosphorylates serine 209 at the C-terminus of the KDEL receptor and this would trigger its recruitment into the Golgi-ER retrograde pathway by promoting ARF-GAP and coatomer association and sorting into COPI-coated carriers.
